AMID growing attention being paid in Massachusetts to the high cost of prescription drugs, independent pharmacists are pointing a finger at a little known culprit: the middlemen who mediate between drug manufacturers, insurers, and pharmacies.  The independent pharmacists released a study Thursday arguing that a particular pricing practice used by pharmacy benefit managers, or PBMs, is unnecessarily driving up the cost of(...)

Read More »